SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Barr Laboratory BRL -- Ignore unavailable to you. Want to Upgrade?

To: harkenman who wrote (143)12/15/1998 6:12:00 AM
From: harkenman  Respond to of 207
 
Barr Labs Says Defense Dept OKs Warfarin
Brand Designation

Dow Jones Newswires

POMONA, N.Y. -- Barr Laboratories Inc. (BRL) said the Defense Department
approved replacing the specific brand designation, "Coumadin brand (DuPont)
only" with "Warfarin Oral."

In a press release Monday, Barr Laboratories said the unanimous decision by the
department's pharmacy and therapeutics committee lets military medical
treatment facilities decide which product to use on their own.

Barr Laboratories makes a generic version of DuPont Pharmacueticals Co.'s (DD)
Coumadin brand warfarin anti-coagulant.

Barr Laboratories develops, manufactures and markets generic and proprietary
pharmaceuticals.



To: harkenman who wrote (143)12/21/1998 12:05:00 AM
From: E. Graphs  Read Replies (1) | Respond to of 207
 
BRL is still in an uptrend. It may consolidate here, but I'm not expecting to see anything less than 41.

At this point I'm long, so not as concerned with the day-to-day other than to note volume. I expect to see the stock in the 60's ......jmho.

Agreed.......new warehouse deal sounds like smart growth.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News